For pernicious anaemia or malabsorption conditions, intramuscular hydroxocobalamin injections are the standard treatment, usually given every 2-3 months after an initial loading regimen
More extensive, well-designed research is needed before definitive statements can be made
Expanding application scope to explore interventions in aging-related diseases (neurodegenerative diseases, cardiovascular diseases, metabolic diseases), providing new strategies for their prevention and treatment
We tailor your dose and schedule to your needs, guided by your symptoms and lab results, and adjust the plan as needed
We acknowledge that hospitals and ASCs may have expended resources to implement SDOH screenings
Get In Touch Not quite sure what you need